Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 382 publications
Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure: An Analysis of the DAPA ACT HF-TIMI 68 Trial.
Journal: JACC. Heart failure
Published: July 27, 2026
Oral Semaglutide and CV Benefits in the SOUL Trial: How Do Baseline or Changes in HbA1c or BMI Affect Clinical Outcomes?
Journal: The Journal of clinical endocrinology and metabolism
Published: April 10, 2026
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
Journal: JAMA cardiology
Published: March 25, 2026
Sodium Glucose Cotransporter-2 Inhibitors are Not Associated with Amputation After Lower Extremity Revascularization in Patients with Diabetes.
Journal: Annals of vascular surgery
Published: February 20, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials.
Journal: Diabetes, obesity & metabolism
Published: February 11, 2026
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: February 02, 2026
Dapagliflozin in Patients With Heart Failure Across the Care Spectrum: A Meta-Analysis of DAPA-HF, DELIVER, and DAPA ACT HF-TIMI 68.
Journal: JACC. Heart failure
Published: January 16, 2026
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease.
Journal: Journal of the American College of Cardiology
Published: August 26, 2025
Oral Semaglutide and Cardiovascular Outcomes. Reply.
Journal: The New England journal of medicine
Published: August 13, 2025
Last Updated: 09/26/2026